recilisib   Click here for help

GtoPdb Ligand ID: 11620

Synonyms: EX-RAD® | ON 01210 | ON-01210
Compound class: Synthetic organic
Comment: Recilisib is a small molecule protein kinase inhibitor that modulates MAPK signalling via up-regulation of the PI3-kinase/AKT pathways [2]. It was developed by Onconova Therapeutics for radioprotective action [2]. Used experimentally as the sodium salt.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 79.82
Molecular weight 336.02
XLogP 3.83
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Clc1ccc(cc1)CS(=O)(=O)/C=C/c1ccc(cc1)C(=O)O
Isomeric SMILES Clc1ccc(cc1)CS(=O)(=O)/C=C/c1ccc(cc1)C(=O)O
InChI InChI=1S/C16H13ClO4S/c17-15-7-3-13(4-8-15)11-22(20,21)10-9-12-1-5-14(6-2-12)16(18)19/h1-10H,11H2,(H,18,19)/b10-9+
InChI Key KBEKQQJUNVQLDZ-MDZDMXLPSA-N
References
1. Ghosh SP, Kulkarni S, Perkins MW, Hieber K, Pessu RL, Gambles K, Maniar M, Kao TC, Seed TM, Kumar KS. (2012)
Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD(R) in mice.
J Radiat Res, 53 (4): 526-36. [PMID:22843617]
2. Kang AD, Cosenza SC, Bonagura M, Manair M, Reddy MV, Reddy EP. (2013)
ON01210.Na (Ex-RAD®) mitigates radiation damage through activation of the AKT pathway.
PLoS One, 8 (3): e58355. [PMID:23505494]